Effects of Thoracentesis |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Pleural effusion (PE) often causes abnormal pulmonary gas exchange. Thoracentesis is commonly
used to relieve dyspnea in patients with PE, but its effect upon arterial oxygenation is varied and poorly understood. This investigation sought to: (1) characterize the distribution of ventilation-perfusion (
A/
) ratios in patients with PE and ( 2) assess the effects of PE drainage by thoracentesis
upon pulmonary gas exchange. We studied nine patients (two females) with a mean age of 39 ± 20 (SD) yr. All of them had PE of recent clinical onset (< 2 wk of symptoms), without other apparent
medical conditions. Before thoracentesis, PaO2 was 82.3 ± 10.2 mm Hg and AaPO2 was 28.7 ± 10.0 mm Hg. Patients had broadened unimodal
A/
distributions with small amounts of blood flow perfusing lung units with low
A/
ratios ( < 0.1) (1.4 ± 2.2%) and mild intrapulmonary shunt (6.9 ± 6.7%). PaO2 was significantly related to the amount of shunt (rho =
0.82; p < 0.01) but not to the
percentage of blood flow perfusing low
A/
units. While thoracentesis drained 693 ± 424 ml of
fluid and caused a significant fall in mean pleural pressure (by
10.7 ± 7.1 mm Hg; p < 0.01), PaO2,
AaPO2, and shunt remained unchanged; only the amount of blood flow perfusing low
A/
ratios increased slightly (2.4 ± 2.6%; p < 0.05). This study shows that: (1) intrapulmonary shunt is the main
mechanism underlying arterial hypoxemia in patients with PE and (2) effective thoracentesis has minor short-term effects upon pulmonary gas exchange. These findings are in accord with delayed
(> 30 min) pulmonary volume re-expansion after thoracentesis with or without the coexistence of
mild ex vacuo pulmonary edema. Agustí AGN, Cardús J, Roca J, Grau JM, Xaubet A, Rodriguez-Roisin R. Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis.
| |
INTRODUCTION |
|---|
|
|
|---|
Pleural effusion (PE) is a common clinical problem that frequently causes dyspnea and abnormal arterial oxygenation
(1). However, the mechanisms underlying this latter effect remain unsettled. Although lung collapse due to the accumulation of pleural fluid is a likely contributor, measurements of
pulmonary mechanics in laboratory animals (2) and in patients (3) suggest that the lungs may actually "float" on the
PE, an effect that would minimize the impact of atelectasis
and subsequent shunting. That the size of the effusion has a
small effect on pulmonary gas exchange (4) appears to support this latter hypothesis. To date, however, ventilation-perfusion (
A/
) distributions in patients with PE have not been
adequately characterized. Only a case report (4) has used the
multiple inert gas elimination technique (MIGET) (7, 8) to
define them appropriately in a single patient.
Alternatively, the drainage of PE by thoracentesis is very
effective in relieving dyspnea (1, 9), but its effect upon arterial
oxygenation is variable. Pa O2 can improve (10), remain unchanged (13), or deteriorate (14, 15) after drainage. These
contrasting findings have been explained on the basis of the
presence or absence of concomitant underlying lung parenchymal disease, nature and chronicity of the PE, and/or differences in the technique used to drain it, timing of drainage, or
volume drained (10, 15). Nonetheless, its effect upon the
A/
distributions have not been assessed as yet. In this investigation, we used the MIGET in patients with PE of recent
clinical onset to characterize the
A/
distributions and also
to assess their response to the effects of PE drainage by thoracentesis. We hypothesized that pleural effusion would cause
regions of intrapulmonary shunt or of low
A/
, or both, and
that the drainage would induce a variable degree of gas exchange improvement, other things being equal.
| |
METHODS |
|---|
|
|
|---|
Patients
We studied nine consecutive patients (two females) with PE of recent clinical onset ( < 2 wk of symptoms). A positive diagnosis of tuberculosis was obtained in six patients, one patient had PE related to rheumatoid arthritis, and the remaining two patients had PE of unknown cause. None of them had cardiac failure or clinical evidence of any other disease, such as chronic obstructive pulmonary disease, asthma, lung fibrosis, and/or liver cirrhosis that could potentially confound pulmonary gas exchange. The main clinical and functional characteristics of the patients are shown in Table 1. There was a moderate restrictive ventilatory defect with a moderate low-transfer factor (DLCO). This study was approved by the Ethics Committee of the Hospital Clinic. All patients gave written consent after being fully informed of the purpose, characteristics, and nature of the study.
|
Study Design
Patients were always studied at the same time of the day (between 9:00 A.M. and 12:00 P.M.). The day of the study, a forced spirometry (Datospir-2000; Siebel-Med, Barcelona, Spain) was obtained in all patients according to ATS recommendations (18). While the patient was sitting comfortably and under steady-state conditions (see below), a complete set of measurements was obtained before and 30 min after draining the PE, according to the following sequence; (1) heart rate and systemic arterial pressure; (2) respiratory frequency and tidal volume; (3) simultaneous arterial blood and mixed expired gas sampling for both inert and respiratory gas determinations; and (4) cardiac output. Thoracentesis was performed in the sitting position, after local anesthesia, using a 18-gauge needle with an internal diameter of 1.2 mm connected to a standard suction machine (A-70; Industrial Ordisi, Barcelona, Spain) through a three-way stopcock. This setup allowed us the direct measurement of pleural pressure (at the level of the fifth intercostal space) before and after withdrawing PE (HP 7754 B recorder; Hewlett Packard, Waltham, MA) (Table 1). Pleural fluid was evacuated at a constant rate of about 150 ml/min until no more fluid could be obtained or the patient showed discomfort (cough, pain, dyspnea). The amount of volume drained and the duration of drainage were recorded and, from these data, drainage flow was calculated (Table 1). Within three h of thoracentesis, a chest roentgenogram was obtained to rule out the presence of pneumothorax, gross pulmonary edema, or other potential abnormalities.
Measurements and Calculations
Blood samples were anaerobically collected through a polyethylene
catheter (Seldicath; Plastimed, Saing-Lou-La-Foret, France) inserted
into the radial artery of the nondominant hand, after local anesthesia.
PaO2, PaCO2, and pH (IL 1302; Izasa, Barcelona, Spain) as well as hemoglobin concentration and oxyhemoglobin saturation (IL 482; Izasa)
were analyzed in duplicate. The alveolar-arterial PO2 difference (AaPO2)
was calculated according to the standard formula, using the measured
respiratory exchange ratio (R). A low-dead space, low-resistance, nonrebreathing valve (No. 1500; Hans Rudolph, Kansas City, MO) connected to a heated metal mixing chamber was used to collect the mixed
expired gas. Oxygen uptake (
O2) and CO2 production (
CO2) were
calculated from measured mixed expired O2 and CO2 by mass spectrometry (Multigas monitor MS2; BOC-Medishield, London, UK).
Minute ventilation (
E) and respiratory rate were measured using a
calibrated Wright spirometer (Respirometer MK8; BOC-Medical, Essex, UK). A three-lead EKG, heart rate, and systemic arterial pressure
were continuously recorded throughout the study (HP 7830 A monitor and HP 7754 B recorder; Hewlett-Packard). Cardiac output (
T)
was measured in duplicate or triplicate using a 5-mg bolus of indocyanine green injected into the peripheral venous line used for inert gas
infusion (see below), as previously shown (19). Tracings of dye concentration versus time were derived from a densitometer used in conjunction with a DC-410 cuvette transducer (Waters Instruments Inc.,
Rochester, NY) at the peripheral artery site. We obtained the distribution of
A/
ratios using the MIGET, as previously described in
our laboratory (19). Briefly, a mixture of six inert gases with different
solubilities (sulfurhexafluoride [SF6], ethane, cyclopropane, enflurane,
ether, and acetone) dissolved in saline was given at 3 to 5 ml/min
through a peripheral vein. Steady-state conditions were assured by
monitoring end-tidal PCO2 and PO2, respiratory frequency, tidal volume, heart rate, and systemic arterial pressure kept within ± 5% of
variations. Duplicates of arterial blood and mixed expired gas samples
were obtained and the concentrations of inert gases were measured
(HP 5880 A; Hewlett-Packard) (19). Mixed venous inert partial pressures of each inert gas were calculated from arterial and expired gases
using the Fick principle (7, 8, 19). Results of
A/
indices are the
mean of each duplicate.
Statistical Analysis
Results are shown as mean ± SD. The effects of thoracentesis were analyzed using a two-tailed paired t test. Potential correlations between variables of interest were assessed using the Spearman's correlation coefficient (rho). A p value < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
The hemodynamic, ventilatory, and gas exchange data in
these patients, before and after thoracentesis, are shown in
Table 2. Before thoracentesis, heart rate, mean systemic arterial pressure,
T,
E, respiratory rate,
O2, and
CO2 were
within the normal range. Mean PaO2 (range: 69 to 104 mm
Hg), PaCO2, and pH were also within normal limits (Table 2);
the AaPO2 was slightly increased (range: 9 to 46 mm Hg). A
representative
A/
distribution in one of the patients studied is illustrated in Figure 1. All subjects had broadened unimodal
A/
distributions, with small amounts of blood flow
perfusing units with low
A/
ratios ( < 0.1, excluding shunt)
(1.4 ± 2.2%; range: 0% to 6%). The former abnormality caused an increased dispersion of the perfusion distribution
(LogSD Q), whose mean value was 0.72 ± 0.29 (normal values
< 0.6) (19) (range: 0.33 to 1.32). Besides, most of them had
mild intrapulmonary shunt (
A/
ratios < 0.005: 6.9 ± 6.7%;
range: 0% to 23%). The ventilation distribution was normal.
Predicted PaO2 (from the degree of both shunting and
A/
mismatch) and measured Pa O2 were not significantly different,
indicating no impairment in the diffusion of O2 from the alveolar air to the capillary blood (20). The degree of arterial hypoxemia before thoracentesis was significantly related to the
intrapulmonary shunt value (rho =
0.82; p < 0.01) but did
not correlate (rho =
0.40) with the amount of blood flow
perfusing lung units with low
A/
ratios ( < 0.1).
|
|
There were no clinical complications associated with thoracentesis. The mean volume of pleural fluid drained was 693 ± 424 ml. In seven patients, there was a noticeable change in
chest X-ray after thoracentesis. However, all patients still
showed some evidence of PE after thoracentesis. Pleural pressure fell significantly after thoracentesis (from 3.6 ± 7.2 to
7.1 ± 13.0 mm Hg; p < 0.01) (Table 1). Yet, most of the
other physiologic variables remained unchanged (Table 2). In
particular, neither PaO2 nor AaPO2 varied after thoracentesis.
As shown in Figure 2, PaO2 after thoracentesis increased in
four patients, decreased in four others, and remained unchanged in one; in absolute terms, however, changes were of
small magnitude. Similarly, the amount of intrapulmonary
shunt did not vary significantly after thoracentesis (Table 2,
Figure 2). In contrast, the perfusion of low
A/
units increased slightly in the majority of patients (p < 0.05), although, in absolute terms, changes were again of small magnitude (Figure 1). Likewise, the dispersion of the blood flow
distribution (LogSD Q) mildly worsened after thoracentesis in
most patients (Table 2, Figure 2). Changes in pulmonary gas
exchange variables (PaO2, AaPO2, shunt, and/or LogSD Q) after
thoracentesis did not correlate with the fall in pleural pressure
(Figure 3), the volume drained, the timing of drainage, and/or
flow of drainage. Also, predicted PaO2 and measured PaO2 were
close after thoracentesis, again suggesting the lack of alveolar-capillary diffusion limitation or post-pulmonary shunt as factors explaining arterial hypoxemia. The remaining sum of
squares (RSQ) in the present study was 2.4 ± 1.5 (range: 0.65 to 6.8).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Our study demonstrates that intrapulmonary shunt is the principal mechanism underlying defective arterial oxygenation in
patients with PE of recent clinical onset and that thoracentesis
caused very small short-term (within 30 min) changes in pulmonary gas exchange, despite the relatively large amounts of
PE drained and the significant fall in pleural pressure induced.
Only the amount of blood flow perfusing low
A/
units,
hence that of Log SD Q, increased significantly after thoracentesis. However, this change was of small magnitude and did not
influence arterial oxygenation. These observations, though, apply to the particular patients studied herein and may not be
readily extrapolated to patients with chronic PE.
Several studies have investigated the effects of PE on pulmonary gas exchange (5, 11, 12, 15, 21), but only a single case
report (4) unraveled the underlying mechanisms using the MIGET to characterize the distribution of
A/
ratios. Our
study extends this case report to a group of patients with PE of
recent clinical onset, carefully selected to avoid potential confounding clinical factors. Our results show that
A/
distributions in these patients are characterized by the presence of
mild intrapulmonary shunt and the virtual absence of areas
with low
A/
units, likely related to different degrees of
lung collapse caused by the accumulation of fluid in the pleural cavity. Further, we observed that the degree of arterial hypoxemia was significantly related to the value of shunt but not
to the amount of blood flow perfusing low
A/
units. These
findings demonstrate that the main mechanism underlying abnormal oxygenation in patients with PE is the presence of intrapulmonary shunt.
Drainage of PE by thoracentesis is a common procedure in
clinical practice to alleviate dyspnea (1). Yet, there is controversy concerning its effects upon arterial oxygenation because
Pa O2 can improve (10), remain unchanged (13), or deteriorate (14, 15) after it. The presence of other concurrent cardiopulmonary diseases, the etiology and timing of the PE,
and/or methodologic differences have been quoted as potential mechanisms/factors to explain these conflicting findings
(10, 15). We selected our patients to avoid some of these
potential biases. Further, this is the first study that has used
the MIGET to assess the effects of thoracentesis upon the distribution of
A/
ratios. In our patients, despite the relatively
large amounts of PE drained and the significant fall in pleural
pressure induced by thoracentesis, neither Pa O2, AaPO2, or
shunt changed significantly 30 min after thoracentesis. By contrast, the percentage of blood flow perfusing poorly ventilated
lung units increased in most patients, although changes were
small in absolute terms and not related to the volume of pleural fluid drained, the timing of drainage, and/or the drainage flow. Collectively, these observations admit, as least, three different explanations.
Firstly, re-expansion of the lung after thoracentesis may
not be immediate (11, 12, 22). When fluid is aspirated from the
thoracic cavity, the net gain of pulmonary volume is set by the
balance between the compliance of the lung parenchyma and that of the thoracic cavity (11). Therefore, the amount of pleural fluid drained by thoracentesis does not necessarily reflect
the net gain in lung volume after the procedure (9, 22). In
fact, previous studies reported a lack of relationship between
the volume of pleural fluid drained and changes in arterial oxygenation (11, 12). We cannot prove this hypothesis because,
unfortunately, we did not have sequential
A/
or lung volume measurements over a period of a few hours after thoracentesis. However, pleural pressure became quite negative after
thoracentesis without a parallel change in LogSD Q (Figure 3),
hence indicating that the underlying lung was not expanding
after drainage.
Secondly, previous studies of lung mechanics in patients
with PE have suggested that the lung actually floats in the
fluid of the pleural cavity, hence minimizing the impact of pulmonary collapse (2). If this was true, effective drainage of PE
by thoracentesis should be expected to cause small changes in
the distribution of
A/
ratios despite reducing the pleural
pressure significantly, as it actually occurred.
Thirdly, an alternative mechanism invoked to explain impaired arterial oxygenation after thoracentesis is the development of ex vacuo pulmonary edema (14, 15, 22). Although the
increase in the percentage of blood flow perfusing low
A/
units ( < 0.1) after thoracentesis is compatible with this phenomenon, the lack of change in intrapulmonary shunt after
the procedure does not seemingly support this contention; further, the chest roentgenogram obtained after the study did not
show the presence of alveolar infiltrates suggestive of pulmonary edema. However, our results cannot rule out completely
this potential additional mechanism. Unfortunately, other
types of information that may have potentially provided relevant data on this subject, such as a CT scan after thoracentesis,
were not available.
In summary, this study shows that mild intrapulmonary
shunt is the cardinal mechanism underlying arterial hypoxemia in patients with PE and that thoracentesis increases
slightly the amount of blood flow perfusing low
A/
units in
the short term. Yet, the latter finding appears to be dissociated
from the volume of pleural fluid drained, the timing of drainage,
or the drainage flow. This is compatible with delayed pulmonary volume re-expansion after thoracentesis with or without
the hypothesis of mild ex vacuo pulmonary edema developing
after thoracentesis.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. J. Roca, Servei Pneumologia i Al.lèrgia Respiratòria, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain.
(Received in original form December 13, 1996 and in revised form May 21, 1997).
Dr. Agustí's present address is Servei de Pneumologia, Hospital Universitari Son Dureta, Palma Mallorca, Spain.Acknowledgments: The writers thank the technical staff of the Gabinet de Funció Pulmonar of the Servei de Pneumologia i Al.lèrgia Respiratòria (Hospital Clinic, Barcelona) for their help during the study and to J. Gea, M.D., for his unselfish input at the inception of the study.
Supported in part by Grant 96/0897 from the Fondo de Investigación Sanitaria (FIS) and the Commissionat per a Universitats i Recerca de la Generalitat de Catalunya (1995-SGR-00446).
| |
References |
|---|
|
|
|---|
1. Light, R. W. 1995. Pleural Diseases. Williams & Wilkins, Baltimore.
2.
Krell, W. S., and
J. R. Rodarte.
1985.
Effects of acute pleural effusion on
respiratory system mechanics in dogs.
J. Appl. Physiol.
59:
1458-1463
3. Anthonisen, N. R., and R. R. Martin. 1977. Regional lung function in pleural effusion. Am. Rev. Respir. Dis. 116: 201-207 [Medline].
4. Gillespie, D. J., and K. Rehder. 1989. Effect of positional change on ventilation-perfusion distribution in unilateral pleural effusion. Intensive Care Med. 15: 266-268 [Medline].
5.
Sonnenblick, M.,
E. Melzer, and
A. J. Rosin.
1983.
Body positional effect on gas exchange in unilateral pleural effusion.
Chest
83:
784-786
6. Yoo, O. H., and E. Y. Ting. 1964. The effects of pleural effusion on pulmonary function. Am. Rev. Respir. Dis. 89: 55-63 .
7.
Wagner, P. D.,
P. F. Naumann,
R. B. Laravuso, and
J. B. West.
1974.
Simultaneous measurement of eight foreign gases in blood by gas chromatography.
J. Appl. Physiol.
36:
600-605
8.
Evans, J. W., and
P. D. Wagner.
1977.
Limits on ·VA/
distributions from
analysis of experimental inert gas elimination technique.
J. Appl. Physiol.
42:
889-898
9. Estenne, M., J. C. Yernault, and A. de Troyer. 1983. Mechanism of relief of dyspnea after thoracentesis in patients with large pleural effusions. Am. J. Med. 74: 813-819 [Medline].
10. Neff, T. A., and B. D. Buchanan. 1975. Tension pleural effusion. Am. Rev. Respir. Dis. 111: 543-548 [Medline].
11.
Brown, N. E.,
N. Zamel, and
A. Aberman.
1978.
Changes in pulmonary
mechanics and gas exchange following thoracocentesis.
Chest
74:
540-542
12.
Perpiñá, M.,
E. Benlloch,
V. Marco,
F. Abad, and
D. Nauffal.
1983.
Effects of thoracocentesis on pulmonary gas exchange.
Thorax
38:
747-750
13. Karetzky, M. S., G. A. Kothari, J. A. Fourre, and A. U. Khan. 1978. Effects of thoracocentesis on arterial oxygen tension. Respiration 36: 96-103 [Medline].
14. Trapnell, D. H., and J. G. B. Thurston. 1970. Unilateral pulmonary oedema after pleural aspiration. Lancet 661: 1367-1369 .
15.
Brandstetter, R. D., and
R. P. Cohen.
1979.
Hypoxemia after thoracocentesis: a predictable and treatable condition.
J.A.M.A.
242:
1060-1061
16. Roca, J., J. Sanchis, A. Agustí-Vidal, J. Segarra, D. Navajas, R. Rodriguez-Roisin, P. Casan, and S. Sans. 1986. Spirometric reference values for a mediterranean population. Bull Eur. Physiopathol. Respir. 22: 217-224 [Medline].
17. Roca, J., R. Rodriguez-Roisin, E. Cobo, F. Burgos, J. Pérez, and J. L. Clausen. 1990. Single-breath carbon monoxide diffusing capacity (DLCO) prediction equations for a mediterranean population. Am. Rev. Respir. Dis. 141: 1026-1032 [Medline].
18. American Thoracic Society. 1995. Standardization of spirometry. 1994 update. Am. J. Respir. Crit. Care Med. 152: 1107-1136 [Medline].
19.
Roca, J., and
P. D. Wagner.
1994.
Contribution of the multiple inert gas
elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique.
Thorax
49:
815-824
20. Agustí, A. G. N., J. Roca, R. Rodriguez-Roisin, J. Gea, A. Xaubet, and P. D. Wagner. 1991. Mechanisms of gas exchange impairment in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143: 219-225 [Medline].
21.
Gillespie, D. J., and
K. Rehder.
1987.
Body position and ventilation-perfusion relationships in unilateral pulmonary disease.
Chest
91:
75-79
22. Doerschuk, C. M., M. F. Allard, and M. J. Oyarzún. 1990. Evaluation of reexpansion pulmonary edema following unilateral pneumothorax in rabbits and the effect of superoxide dismutase. Exp. Lung Res. 16: 355-367 [Medline].
This article has been cited by other articles:
![]() |
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Doelken, R. Abreu, S. A. Sahn, and P. H. Mayo Effect of thoracentesis on respiratory mechanics and gas exchange in the patient receiving mechanical ventilation. Chest, November 1, 2006; 130(5): 1354 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. de Waele, E. Hoste, D. Benoit, K. Vandewoude, S. Delaere, F. Berrevoet, and F. Colardyn The Effect of Tube Thoracostomy on Oxygenation in ICU Patients J Intensive Care Med, March 1, 2003; 18(2): 100 - 104. [Abstract] [PDF] |
||||
![]() |
P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123 (2009): 284S - 311S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Dakin and M Griffiths The pulmonary physician in critical care 1: Pulmonary investigations for acute respiratory failure Thorax, January 1, 2002; 57(1): 79 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Pien, M. J. Gant, C. L. Washam, and D. H. Sterman Use of an Implantable Pleural Catheter for Trapped Lung Syndrome in Patients With Malignant Pleural Effusion Chest, June 1, 2001; 119(6): 1641 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Krowka, G. A. Wiseman, O. L. Burnett, J. R. Spivey, T. Therneau, M. K. Porayko, and R. H. Wiesner Hepatopulmonary Syndrome : A Prospective Study of Relationships Between Severity of Liver Disease, PaO2 Response to 100% Oxygen, and Brain Uptake After 99mTc MAA Lung Scanning Chest, September 1, 2000; 118(3): 615 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J KROWKA Hepatopulmonary syndromes Gut, January 1, 2000; 46(1): 1 - 4. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |